View in EDS HTML Full Text PDF Full Text

Efficacy of first-line checkpoint inhibitors in combination with chemotherapy in high-grade extrapulmonary metastatic neuroendocrine carcinomas.

Saved in:
Bibliographic Details
Title: Efficacy of first-line checkpoint inhibitors in combination with chemotherapy in high-grade extrapulmonary metastatic neuroendocrine carcinomas.
Authors: Gile JJ; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA., McGarrah PW; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA., Leventakos K; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA., Sonbol MB; Division of Hematology/Oncology, Mayo Clinic, Phoenix, Arizona, USA., Starr JS; Division of Hematology/Oncology, Mayo Clinic, Jacksonville, Florida, USA., Eiring RA; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA., Hobday TJ; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA., Halfdanarson TR; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Source: Journal of neuroendocrinology [J Neuroendocrinol] 2023 May; Vol. 35 (5), pp. e13283. Date of Electronic Publication: 2023 May 25.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Wiley & Sons Country of Publication: United States NLM ID: 8913461 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2826 (Electronic) Linking ISSN: 09538194 NLM ISO Abbreviation: J Neuroendocrinol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37229903
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy of first-line checkpoint inhibitors in combination with chemotherapy in high-grade extrapulmonary metastatic neuroendocrine carcinomas.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gile+JJ%22">Gile JJ</searchLink>; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22McGarrah+PW%22">McGarrah PW</searchLink>; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Leventakos+K%22">Leventakos K</searchLink>; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Sonbol+MB%22">Sonbol MB</searchLink>; Division of Hematology/Oncology, Mayo Clinic, Phoenix, Arizona, USA.<br /><searchLink fieldCode="AU" term="%22Starr+JS%22">Starr JS</searchLink>; Division of Hematology/Oncology, Mayo Clinic, Jacksonville, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Eiring+RA%22">Eiring RA</searchLink>; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Hobday+TJ%22">Hobday TJ</searchLink>; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Halfdanarson+TR%22">Halfdanarson TR</searchLink>; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228913461%22">Journal of neuroendocrinology</searchLink> [J Neuroendocrinol] 2023 May; Vol. 35 (5), pp. e13283. <i>Date of Electronic Publication: </i>2023 May 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley+%26+Sons%22">Wiley & Sons </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8913461 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2826 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209538194%22">09538194 </searchLink><i>NLM ISO Abbreviation: </i>J Neuroendocrinol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37229903
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/jne.13283
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e13283
    Titles:
      – TitleFull: Efficacy of first-line checkpoint inhibitors in combination with chemotherapy in high-grade extrapulmonary metastatic neuroendocrine carcinomas.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gile JJ
      – PersonEntity:
          Name:
            NameFull: McGarrah PW
      – PersonEntity:
          Name:
            NameFull: Leventakos K
      – PersonEntity:
          Name:
            NameFull: Sonbol MB
      – PersonEntity:
          Name:
            NameFull: Starr JS
      – PersonEntity:
          Name:
            NameFull: Eiring RA
      – PersonEntity:
          Name:
            NameFull: Hobday TJ
      – PersonEntity:
          Name:
            NameFull: Halfdanarson TR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2023 May
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2826
          Numbering:
            – Type: volume
              Value: 35
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Journal of neuroendocrinology
              Type: main
ResultId 1